Thymic Tumors: Revisiting Autoimmunity to Give a Chance to Immunotherapy

被引：2
作者：
Girard, Nicolas [1 ,2 ]
机构：
[1] Univ Claude Bernard Lyon 1, Univ Lyon, Lyon, France
[2] Inst Curie, Thorax Inst Curie Montsouris, Paris, France
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 03期
关键词：
MYASTHENIA-GRAVIS; EPITHELIAL TUMORS; TRIAL; THYMOMA;
D O I：
10.1016/j.jtho.2018.01.013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：295 / 297
页数：3
相关论文
共 15 条
[1]   A phase II study of pembrolizumab for patients with previously treated advanced thymic epithelial tumor. [J].
Cho, Jinhyun ;
Ahn, Myung-Ju ;
Yoo, Kwai Han ;
Lee, Hansang ;
Kim, Hee Kyung ;
Heo, Mi Hwa ;
Hong, Joo Hyun ;
Sun, Jong-Mu ;
Lee, Se-Hoon ;
Ahn, Jin Seok ;
Park, Keunchil .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[2]   Pembrolizumab in patients with recurrent thymic carcinoma: Results of a phase II study. [J].
Giaccone, Giuseppe ;
Thompson, Jillian ;
McGuire, Colleen ;
Manning, Maria ;
Kallakury, Bhaskar ;
Chahine, Joeffrey J. ;
Subramaniam, Deepa Suresh ;
Liu, Stephen V. ;
Gibney, Geoffrey Thomas ;
Kim, Chul ;
McCutcheon, Justine N. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[3]   Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro [J].
Girard, N. ;
Ruffini, E. ;
Marx, A. ;
Faivre-Finn, C. ;
Peters, S. .
ANNALS OF ONCOLOGY, 2015, 26 :V40-V55
[4]   Thymomas alter the T-cell subset composition in the blood:: a potential mechanism for thymoma-associated autoimmune disease [J].
Hoffacker, V ;
Schultz, A ;
Tiesinga, JJ ;
Gold, R ;
Schalke, B ;
Nix, W ;
Kiefer, R ;
Müller-Hermelink, HK ;
Marx, A .
BLOOD, 2000, 96 (12) :3872-3879
[5]   Thymoma and myasthenia gravis: A clinical study of 1,089 patients from Japan [J].
Kondo, K ;
Monden, Y .
ANNALS OF THORACIC SURGERY, 2005, 79 (01) :219-224
[6]   Aire [J].
Mathis, Diane ;
Benoist, Christophe .
ANNUAL REVIEW OF IMMUNOLOGY, 2009, 27 :287-312
[7]   Pathological central review of 290 thymic epithelial tumors (TET): The national network RYTHMIC experience. [J].
Molina, Thierry ;
Bluthgen, Maria Virginia ;
Chalabreysse, Lara ;
De Montpreville, Vincent Thomas ;
De Muret, Anne ;
Hofman, Veronique ;
Lantuejoul, Sylvie ;
Parrens, Marie ;
Rouquette, Isabelle ;
Secq, Veronique ;
Girard, Nicolas ;
Marx, Alexander ;
Besse, Benjamin .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[8]   Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database [J].
Padda, Sukhmani K. ;
Yao, Xiaopan ;
Antonicelli, Alberto ;
Riess, Jonathan W. ;
Shang, Yue ;
Shrager, Joseph B. ;
Korst, Robert ;
Detterbeck, Frank ;
Huang, James ;
Burt, Bryan M. ;
Wakelee, Heather A. ;
Badve, Sunil S. .
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (03) :436-446
[9]  
Radovich M, CANC CELL IN PRESS
[10]   Evaluation of a Modified Dosing Regimen (2-Weeks on/1-Week off) of Sunitinib as Part of a Phase II Trial in Thymic Carcinoma [J].
Rajan, Arun ;
Kim, Chul ;
Guha, Udayan ;
Szabo, Eva ;
Berman, Arlene ;
Sciuto, Linda ;
Spittler, A. John ;
Trepel, Jane ;
Steinberg, Seth ;
Harris, Pamela ;
Hassan, Raffit ;
Loehrer, Patrick, Sr. .
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) :S313-S314
12